0.6111
Precedente Chiudi:
$0.61
Aprire:
$0.62
Volume 24 ore:
413.08K
Relative Volume:
0.80
Capitalizzazione di mercato:
$64.91M
Reddito:
$38.70M
Utile/perdita netta:
$-117.88M
Rapporto P/E:
-0.3595
EPS:
-1.7
Flusso di cassa netto:
$-92.84M
1 W Prestazione:
-6.59%
1M Prestazione:
-14.92%
6M Prestazione:
-36.48%
1 anno Prestazione:
-46.86%
Adicet Bio Inc Stock (ACET) Company Profile
Nome
Adicet Bio Inc
Settore
Industria
Telefono
617-482-2333
Indirizzo
131 DARTMOUTH STREET, BOSTON
Confronta ACET con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ACET
Adicet Bio Inc
|
0.6111 | 64.91M | 38.70M | -117.88M | -92.84M | -1.70 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
452.16 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
534.91 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
322.06 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
542.47 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
245.16 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Adicet Bio Inc Stock (ACET) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-09-30 | Ripresa | Guggenheim | Buy |
2024-09-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
2023-06-27 | Downgrade | Guggenheim | Buy → Neutral |
2023-06-27 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
2023-06-01 | Downgrade | JP Morgan | Overweight → Neutral |
2022-09-21 | Iniziato | JP Morgan | Overweight |
2022-03-31 | Iniziato | SMBC Nikko | Outperform |
2022-03-08 | Iniziato | Truist | Buy |
2022-03-04 | Iniziato | Jefferies | Buy |
2021-05-18 | Iniziato | BTIG Research | Buy |
2021-04-23 | Iniziato | H.C. Wainwright | Buy |
2021-04-14 | Iniziato | Canaccord Genuity | Buy |
2021-04-08 | Iniziato | Guggenheim | Buy |
2020-11-04 | Iniziato | B. Riley Securities | Buy |
2020-10-27 | Iniziato | JMP Securities | Mkt Outperform |
2020-10-16 | Iniziato | Wedbush | Outperform |
Mostra tutto
Adicet Bio Inc Borsa (ACET) Ultime notizie
Adicet Bio Elects Directors and Approves Key Proposals - TipRanks
Adicet Bio, Inc. (NASDAQ:ACET) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Squarepoint Ops LLC Purchases New Shares in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio To Present At Jefferies Global Healthcare Conference; Webcast At 4:20 PM ET - Nasdaq
Northern Trust Corp Acquires 28,153 Shares of Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
ACETAdicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates - Revista ADVFN
Millennium Management LLC Lowers Position in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference - Business Wire
Adicet Bio’s SWOT analysis: gamma-delta T cell therapy stock faces pivotal year - Investing.com
Adicet Bio, Inc. (NASDAQ:ACET) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
Financial Comparison: Adicet Bio (NASDAQ:ACET) & Trevena (NASDAQ:TRVN) - Defense World
Brokerages Set Adicet Bio, Inc. (NASDAQ:ACET) Price Target at $7.50 - Defense World
Adicet Bio (ACET) Upgraded to Buy: Here's What You Should Know - MSN
Adicet Bio (NASDAQ:ACET) Coverage Initiated at StockNews.com - Defense World
Wedbush Comments on Adicet Bio’s Q3 Earnings (NASDAQ:ACET) - Defense World
What is Wedbush’s Estimate for Adicet Bio Q1 Earnings? - Defense World
Adicet Bio Reports Q1 2025 Results and Updates - TipRanks
Marshall Wace LLP Sells 104,894 Shares of Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates - Bluefield Daily Telegraph
ACET's Cash Reserves Expected to Sustain Operations Until Late 2 - GuruFocus
Adicet Bio, Inc. (NASDAQ:ACET) Shares Acquired by JPMorgan Chase & Co. - Defense World
Reviewing Adicet Bio (NASDAQ:ACET) and HUTCHMED (NASDAQ:HCM) - Defense World
Renaissance Technologies LLC Has $882,000 Holdings in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Update - Defense World
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference - Yahoo Finance
Adicet Bio (NASDAQ:ACET) Rating Increased to Hold at StockNews.com - Defense World
Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting - BioSpace
Adicet Bio Announces Oral Presentation Highlighting Preclinical Adi-270 Data At The American Society Of Gene And Cell Therapy 28Th Annual Meeting - marketscreener.com
We're Keeping An Eye On Adicet Bio's (NASDAQ:ACET) Cash Burn Rate - Yahoo Finance
JMP maintains Market Perform on Adicet Bio shares By Investing.com - Investing.com Canada
JMP maintains Market Perform on Adicet Bio shares - Investing.com
Adicet Bio (NASDAQ:ACET) Now Covered by StockNews.com - Defense World
Adicet Bio appoints Michael Grissinger to its board By Investing.com - Investing.com Canada
Adicet Bio Appoints Michael Grissinger to the Board of Directors - BioSpace
Adicet Bio appoints Michael Grissinger to its board - Investing.com
Adicet Bio Appoints Michael Grissinger to Board - TipRanks
Adicet Bio Appoints Michael Grissinger To The Board Of Directors - marketscreener.com
Adicet Bio Strengthens Board with Ex-Johnson & Johnson VP: Strategic Move for Cell Therapy Pioneer - Stock Titan
Adicet Bio Inc Azioni (ACET) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):